These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 15815973
41. Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes. Zhang X, Marchand C, Pommier Y, Burke TR. Bioorg Med Chem Lett; 2004 Mar 08; 14(5):1205-7. PubMed ID: 14980666 [Abstract] [Full Text] [Related]
42. Active site binding modes of the beta-diketoacids: a multi-active site approach in HIV-1 integrase inhibitor design. Dayam R, Neamati N. Bioorg Med Chem; 2004 Dec 15; 12(24):6371-81. PubMed ID: 15556755 [Abstract] [Full Text] [Related]
43. Implications of HIV-1 M group polymorphisms on integrase inhibitor efficacy and resistance: genetic and structural in silico analyses. Loizidou EZ, Kousiappa I, Zeinalipour-Yazdi CD, Van de Vijver DA, Kostrikis LG. Biochemistry; 2009 Jan 13; 48(1):4-6. PubMed ID: 19090674 [Abstract] [Full Text] [Related]
44. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Kawasuji T, Fuji M, Yoshinaga T, Sato A, Fujiwara T, Kiyama R. Bioorg Med Chem; 2006 Dec 15; 14(24):8420-9. PubMed ID: 17005407 [Abstract] [Full Text] [Related]
45. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors. Barreca ML, Ferro S, Rao A, De Luca L, Zappalà M, Monforte AM, Debyser Z, Witvrouw M, Chimirri A. J Med Chem; 2005 Nov 03; 48(22):7084-8. PubMed ID: 16250669 [Abstract] [Full Text] [Related]
49. Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay. Michelini Z, Galluzzo CM, Negri DR, Leone P, Amici R, Bona R, Summa V, Di Santo R, Costi R, Pommier Y, Marchand C, Palmisano L, Vella S, Cara A. J Virol Methods; 2010 Sep 03; 168(1-2):272-6. PubMed ID: 20558207 [Abstract] [Full Text] [Related]
51. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods. Li P, Tan JJ, Liu M, Zhang XY, Chen WZ, Wang CX. J Biomol Struct Dyn; 2011 Oct 03; 29(2):311-23. PubMed ID: 21875151 [Abstract] [Full Text] [Related]
54. Stabilization of the integrase-DNA complex by Mg2+ ions and prediction of key residues for binding HIV-1 integrase inhibitors. Miri L, Bouvier G, Kettani A, Mikou A, Wakrim L, Nilges M, Malliavin TE. Proteins; 2014 Mar 03; 82(3):466-78. PubMed ID: 24038133 [Abstract] [Full Text] [Related]
55. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase. Sechi M, Sannia L, Carta F, Palomba M, Dallocchio R, Dessì A, Derudas M, Zawahir Z, Neamati N. Antivir Chem Chemother; 2005 Mar 03; 16(1):41-61. PubMed ID: 15739621 [Abstract] [Full Text] [Related]
56. From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes. Bacchi A, Biemmi M, Carcelli M, Carta F, Compari C, Fisicaro E, Rogolino D, Sechi M, Sippel M, Sotriffer CA, Sanchez TW, Neamati N. J Med Chem; 2008 Nov 27; 51(22):7253-64. PubMed ID: 18983138 [Abstract] [Full Text] [Related]